Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells.
about
Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bivalent IAP antagonists, but ...... ociated cIAP1 in cancer cells.
@en
type
label
Bivalent IAP antagonists, but ...... ociated cIAP1 in cancer cells.
@en
prefLabel
Bivalent IAP antagonists, but ...... ociated cIAP1 in cancer cells.
@en
P2093
P2860
P1433
P1476
Bivalent IAP antagonists, but ...... ociated cIAP1 in cancer cells.
@en
P2093
C A Benetatos
C G Begley
G S Kapoor
M A McKinlay
M E Seipel
M R Arnone
S K Chunduru
S M Condon
T Haimowitz
P2860
P2888
P356
10.1038/CDDISCOVERY.2016.46
P577
2017-01-16T00:00:00Z